Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · May 5, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method for assessing the severity of injuries in patients who have experienced serious trauma, such as from a car accident or a high fall. Currently, the tools used to evaluate these patients in the field have some limitations and can be subjective. The researchers want to find out if measuring a substance called capillary lactate, which can be done quickly and easily at the scene of an accident, can help predict how well a patient will do after their injury. This could lead to better care and quicker decisions in emergency situations.
To be eligible for this trial, participants need to be adults over 18 years old who have had a serious injury that requires emergency medical help. They could be involved in an accident or fall from a significant height. Pregnant women can also participate without any risk to themselves or their baby. If someone takes part in the study, they will be asked to give their consent, which can be done later if they are unable to do so right away. It’s important to note that patients with less severe injuries or those who are critically ill when the emergency team arrives will not be included in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 years of age
- * Presenting a potentially serious pre-hospital trauma defined by:
- • o A road accident or a fall of more than 2 metres
- • Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service)
- • And transferred to an emergency facility in the Alpes Maritimes with medical assistance.
- • Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately.
- • Pregnant women may also take part in the study without any risk to themselves or their child.
- Exclusion Criteria:
- • Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
- • Patients under legal protection (guardianship, curatorship)
- • Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Antibes, , France
Cannes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported